Group 1: Company Overview - The company operates as a national high-value medical device distributor, focusing on direct sales and distribution of medical devices, as well as providing centralized operation services for medical consumables to hospitals [2] - As of the signing date of the prospectus, Xiamen Jianfa Medical Health Investment Co., Ltd. holds 51.02% of the company's shares, making it the controlling shareholder [2] - The actual controller of the company is the Xiamen State-owned Assets Supervision and Administration Commission, which indirectly holds 51.02% of the company's shares through its ownership of Jianfa Group and Jianfa Medical [2] Group 2: Fundraising and Financials - The company plans to raise approximately 484.24 million yuan for projects including information system upgrades, centralized operation services for medical consumables, and to supplement working capital [2] - The initial public offering (IPO) price is set at 7.05 yuan per share, with an expected total fundraising amount of 445.51 million yuan, and a net fundraising amount of approximately 363.33 million yuan after deducting issuance costs [3] Group 3: Industry Context - The company plays a crucial role in the medical device supply chain, acting as a hub that connects manufacturers, distributors, and end medical institutions [2] - The reference industry price-earnings ratio for the wholesale industry is 25.73, while the company's offering price results in a price-earnings ratio of 13.29, indicating a potential undervaluation compared to industry peers [1]

Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. has been approved for IPO by the Beijing Stock Exchange, marking it as the 31st company to pass the review this year, with a focus on fine chemical products [1][2]. Company Overview - Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime [1]. - The company is controlled by Juhua Group Co., Ltd., which holds 82.49% of its shares, while the actual controller is the Zhejiang Provincial State-owned Assets Supervision and Administration Commission, owning 90% of Juhua Group [2]. IPO Details - Jinhua New Materials plans to publicly issue up to 32,666,667 shares, ensuring that public shareholders will hold at least 25% of the total share capital post-IPO [2]. - The IPO aims to raise approximately 593 million yuan (59,300.25 million) for projects including a 60kt/a high-end coupling agent project, a 500 tons/year JH-2 pilot project, and the construction of a ketoxime industry chain smart factory [3]. Review and Inquiry - The review meeting raised inquiries regarding the authenticity of operating performance, independence from the controlling shareholder, and compliance with environmental regulations [5].